Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.87B 4.48B 572M 500M 462M 424M 803M 55.1B 817M 5.51B 2.17B 26.91B 2.15B 2.1B 92.9B P/E 2026 *
8.52x
P/E 2027 * 7.56x
Enterprise Value 3.87B 4.48B 572M 500M 462M 424M 803M 55.1B 817M 5.51B 2.17B 26.91B 2.15B 2.1B 92.9B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.51x
Free-Float
-
Yield 2026 *
5.29%
Yield 2027 * 5.95%
07-09 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
06-29 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
06-29 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
06-12 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
05-26 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
04-27 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
03-30 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
03-27 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
03-27 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
03-26 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
02-06 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
01-13 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
12-30 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-2.78%
1 week+6.71%
Current month+9.38%
1 month+3.24%
3 months-11.84%
6 months-20.99%
Current year-20.63%
1 week 3.29
Extreme 3.29
3.64
1 month 3.07
Extreme 3.07
3.64
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.52
3 years 3.07
Extreme 3.07
7.41
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 03/06/2025
Comptroller/Controller/Auditor 48 03/06/2025
Corporate Secretary 43 27/11/2025
Director TitleAgeSince
Director/Board Member 69 11/06/2018
Director/Board Member 66 05/02/2026
Director/Board Member 82 11/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%+6.71%-32.69%-48.30% 588M
-1.32%+6.33%-8.03%-5.29% 13.73B
-3.30%+12.63%-26.94%-50.04% 5.45B
-2.47%+7.12%+1.38%-2.05% 4.84B
-5.06%+8.62%+9.27%-34.00% 4.29B
-2.65%-5.70%+5.95%-5.37% 3.85B
0.00%+8.92%-5.20%-4.44% 3.57B
-3.45%+9.54%-3.88%+11.29% 3.51B
-3.77%-0.32%-12.63%-22.78% 2.52B
-2.82%+2.80%-1.62%+50.74% 1.92B
Average -2.76%+3.29%-7.44%-11.02% 4.43B
Weighted average by Cap. -2.45%+3.15%-6.19%-10.99%

Financials

2026 *2027 *
Net sales 6.98B 8.08B 1.03B 901M 833M 765M 1.45B 99.32B 1.47B 9.94B 3.9B 48.5B 3.87B 3.79B 167B 7.56B 8.75B 1.12B 976M 903M 828M 1.57B 108B 1.59B 10.76B 4.23B 52.54B 4.19B 4.1B 181B
Net income 454M 526M 67.1M 58.65M 54.24M 49.77M 94.2M 6.47B 95.83M 647M 254M 3.16B 252M 246M 10.9B 514M 594M 75.81M 66.26M 61.28M 56.23M 106M 7.3B 108M 731M 287M 3.57B 285M 278M 12.32B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
17/07/26 HK$3.500 -2.78% 1,048,000
16/07/26 HK$3.600 +4.96% 1,530,000
15/07/26 HK$3.430 +2.08% 514,000
14/07/26 HK$3.360 +0.30% 789,424
13/07/26 HK$3.350 +2.45% 1,000,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.024CNY
Average target price
4.601CNY
Spread / Average Target
+52.13%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock